Zacks Investment Management grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 145,361 shares of the healthcare conglomerate’s stock after purchasing an additional 3,447 shares during the quarter. Zacks Investment Management’s holdings in UnitedHealth Group were worth $26,953,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in UNH. Regal Wealth Group Inc. raised its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. raised its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after buying an additional 4 shares during the period. RB Capital Management LLC raised its stake in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Altfest L J & Co. Inc. raised its stake in shares of UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after purchasing an additional 10 shares during the last quarter. Finally, Hanson McClain Inc. raised its stake in shares of UnitedHealth Group by 1.7% in the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after purchasing an additional 15 shares during the last quarter. 86.20% of the stock is currently owned by institutional investors.

In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 63,206 shares of company stock worth $12,683,669 over the last ninety days. Insiders own 0.89% of the company’s stock.

Several brokerages have recently commented on UNH. Jefferies Group reissued a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research note on Friday. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Friday. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a research note on Friday. Wells Fargo & Company reissued an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $224.56.

UnitedHealth Group Incorporated (UNH) traded down $1.39 during midday trading on Monday, reaching $226.78. The company’s stock had a trading volume of 3,326,000 shares, compared to its average volume of 3,107,989. UnitedHealth Group Incorporated has a twelve month low of $156.09 and a twelve month high of $229.22. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $219,765.13, a P/E ratio of 23.62, a price-to-earnings-growth ratio of 1.68 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter last year, the business posted $2.17 earnings per share. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. analysts expect that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.26%.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-stake-lifted-by-zacks-investment-management/1743456.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.